Literature DB >> 1285868

The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis.

P Langevitz1, L Klein, M Pras, A Many.   

Abstract

The effect of cyclophosphamide pulse therapy given in relatively small doses (10 mg/kg per pulse) in 17 females with lupus nephritis has been studied. Four females developed menopause; in one transient amenorrhea occurred. No changes in menstrual cycle were noted in the other 11 females, four of whom subsequently delivered five normal babies. These data suggest the relative safety of small doses of cyclophosphamide pulse therapy on gonadal function in females under age 40 years.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285868     DOI: 10.1111/j.1600-0897.1992.tb00780.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  10 in total

1.  Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus.

Authors:  Pintip Ngamjanyaporn; Ammarin Thakkinstian; Oravan Verasertniyom; Porntip Chatchaipun; Monchand Vanichapuntu; Kanokrat Nantiruj; Kitti Totemchokchyakarn; John Attia; Suchela Janwityanujit
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

Review 2.  Pregnancy in systemic lupus erythematosus.

Authors:  C C Mok; R W Wong
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

Review 3.  New insights into pregnancy-related complications in systemic lupus erythematosus.

Authors:  Doruk Erkan; Lisa Sammaritano
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

4.  Ovarian failure in SLE patients using pulse cyclophosphamide: comparison of different regimes.

Authors:  Simone Appenzeller; Paula F Blatyta; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

5.  Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.

Authors:  Abdurhman Saud Alarfaj; Najma Khalil
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

6.  Pregnancy in granulomatous vasculitis.

Authors:  F Lima; N Buchanan; L Froes; S Kerslake; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

7.  Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.

Authors:  Sayumi Baba; Yasuhiro Katsumata; Yasushi Kawaguchi; Takahisa Gono; Tomoko Sugiura; Tokiko Kanno; Masako Hara; Hisashi Yamanaka
Journal:  BMC Womens Health       Date:  2011-06-10       Impact factor: 2.809

8.  Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review.

Authors:  Sai Yan Yuen; Adriana Krizova; Janine M Ouimet; Janet E Pope
Journal:  Open Rheumatol J       Date:  2008-12-31

Review 9.  Treatment of systemic lupus erythematosus.

Authors:  Kathryn P McKeon; Simon H Jiang
Journal:  Aust Prescr       Date:  2020-06-02

10.  Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.

Authors:  Shefali Khanna Sharma; Siddharth Jain; Pooja Bahl; Pragna Potturi; Manish Rathi; Shankar Naidu; Naresh Sachdeva; Varun Dhir; Sanjay Jain
Journal:  Arthritis Res Ther       Date:  2020-08-14       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.